Dr Andrew A Fedder, MD | |
78-6831 Ali'i Drive, Suite 422, Kailua-kona, HI 96740 | |
(808) 747-8321 | |
(808) 323-2119 |
Full Name | Dr Andrew A Fedder |
---|---|
Gender | Male |
Speciality | General Surgery |
Experience | 26 Years |
Location | 78-6831 Ali'i Drive, Kailua-kona, Hawaii |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588720205 | NPI | - | NPPES |
HI03677 | Medicaid | HI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | MD13027 (Hawaii) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Clovis Community Medical Center | Clovis, CA | Hospital |
Community Regional Medical Center | Fresno, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Community Health Partners | 6608280268 | 414 |
News Archive
Researchers at UCLA's Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research have successfully established the foundation for using hematopoietic (blood-producing) stem cells from the bone marrow of patients with sickle cell disease to treat the disease.
The American Telemedicine Association (ATA) has just announced its latest standard publication, 'A Blueprint for Telerehabilitation Guidelines,' which discusses the key administrative, clinical technical and ethical principles that should be considered in the course of providing telerehabilitation services. The purpose of these guidelines is to inform and assist practitioners in providing effective and safe services based on client needs, current empirical evidence, and available technologies.
It should be possible to significantly improve the response of common cancers to existing "classical" chemotherapy drugs, say scientists at Cold Spring Harbor Laboratory (CSHL), by introducing agents that alter the interaction of cancer cells with their immediate surroundings, called the tumor microenvironment.
Kronos Incorporated today announced additional details regarding its pending acquisition of API Healthcare Corporation to organizations attending the HIMSS conference being held this week. The closing of the transaction is subject to regulatory approval and customary closing conditions.
Scientists have revealed that an anti-obesity drug changes the way the brain responds to appetising, high-calorie foods in obese individuals. This insight may aid the development of new anti-obesity drugs which reduce the activity in the regions of the brain stimulated by the sight of tasty foods.
› Verified 2 days ago
Entity Name | Community Health Partners |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952912420 PECOS PAC ID: 6608280268 Enrollment ID: O20210122001714 |
News Archive
Researchers at UCLA's Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research have successfully established the foundation for using hematopoietic (blood-producing) stem cells from the bone marrow of patients with sickle cell disease to treat the disease.
The American Telemedicine Association (ATA) has just announced its latest standard publication, 'A Blueprint for Telerehabilitation Guidelines,' which discusses the key administrative, clinical technical and ethical principles that should be considered in the course of providing telerehabilitation services. The purpose of these guidelines is to inform and assist practitioners in providing effective and safe services based on client needs, current empirical evidence, and available technologies.
It should be possible to significantly improve the response of common cancers to existing "classical" chemotherapy drugs, say scientists at Cold Spring Harbor Laboratory (CSHL), by introducing agents that alter the interaction of cancer cells with their immediate surroundings, called the tumor microenvironment.
Kronos Incorporated today announced additional details regarding its pending acquisition of API Healthcare Corporation to organizations attending the HIMSS conference being held this week. The closing of the transaction is subject to regulatory approval and customary closing conditions.
Scientists have revealed that an anti-obesity drug changes the way the brain responds to appetising, high-calorie foods in obese individuals. This insight may aid the development of new anti-obesity drugs which reduce the activity in the regions of the brain stimulated by the sight of tasty foods.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Andrew A Fedder, MD 78-6831 Ali'i Drive, Suite 328, Kailua-kona, HI 96740 Ph: (808) 747-8321 | Dr Andrew A Fedder, MD 78-6831 Ali'i Drive, Suite 422, Kailua-kona, HI 96740 Ph: (808) 747-8321 |
News Archive
Researchers at UCLA's Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research have successfully established the foundation for using hematopoietic (blood-producing) stem cells from the bone marrow of patients with sickle cell disease to treat the disease.
The American Telemedicine Association (ATA) has just announced its latest standard publication, 'A Blueprint for Telerehabilitation Guidelines,' which discusses the key administrative, clinical technical and ethical principles that should be considered in the course of providing telerehabilitation services. The purpose of these guidelines is to inform and assist practitioners in providing effective and safe services based on client needs, current empirical evidence, and available technologies.
It should be possible to significantly improve the response of common cancers to existing "classical" chemotherapy drugs, say scientists at Cold Spring Harbor Laboratory (CSHL), by introducing agents that alter the interaction of cancer cells with their immediate surroundings, called the tumor microenvironment.
Kronos Incorporated today announced additional details regarding its pending acquisition of API Healthcare Corporation to organizations attending the HIMSS conference being held this week. The closing of the transaction is subject to regulatory approval and customary closing conditions.
Scientists have revealed that an anti-obesity drug changes the way the brain responds to appetising, high-calorie foods in obese individuals. This insight may aid the development of new anti-obesity drugs which reduce the activity in the regions of the brain stimulated by the sight of tasty foods.
› Verified 2 days ago